Kemwell Biopharma Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Kemwell Biopharma Pvt Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10805
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Kemwell Biopharma Pvt Ltd (Kemwell) formerly Kemwell Pvt Ltd a subsidiary of Recipharm AB is a healthcare solutions provider that offers product development and manufacturing solutions. The organization provides contract pharmaceutical development and manufacturing organization and concentrates on the development of drugs. It offers services such as drug prototype development, pre-formulation,formulation development, analytical method development and validation, process optimization, stability testing and storage, and scale-up. Kemwell provides comparator product modification for blinding studies, lab and pilot scale manufacture, clinical packaging and labeling, registration batch manufacture, and technology transfer. The organization offers products in dosage forms of oral, semi-solids, liquids, parenteral and first-in-human formulations. It operates in India, Sweden and the US. Kemwell is headquartered in Bangalore, Karnataka, India.

Kemwell Biopharma Pvt Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deal Details 9
Partnerships 9
Kemwell Biopharma Enters into Co-Development Agreement for Monoclonal Antibody Therapeutics 9
Acquisition 10
Recipharm Acquires Kemwell Biopharma for USD120 Million 10
Recipharm Acquires Kemwell and Cirrus Pharma from Kemwell Biopharma 11
Kemwell Biopharma Acquires Cirrus Pharma 13
Kemwell Biopharma Pvt Ltd – Key Competitors 14
Kemwell Biopharma Pvt Ltd – Key Employees 15
Kemwell Biopharma Pvt Ltd – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Other Significant Developments 17
May 17, 2017: Kemwell Biopharma Supplies Biologics Drug Substance for Phase 1 Clinical Trials for US IND Filing 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Kemwell Biopharma Enters into Co-Development Agreement for Monoclonal Antibody Therapeutics 9
Recipharm Acquires Kemwell Biopharma for USD120 Million 10
Recipharm Acquires Kemwell and Cirrus Pharma from Kemwell Biopharma 11
Kemwell Biopharma Acquires Cirrus Pharma 13
Kemwell Biopharma Pvt Ltd, Key Competitors 14
Kemwell Biopharma Pvt Ltd, Key Employees 15

List of Figures
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[Kemwell Biopharma Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • William Demant Holding AS (WDH):医療機器:M&Aディール及び事業提携情報
    Summary William Demant Holding AS (WDH) is a provider of hearing healthcare solutions that develops, manufactures and distributes products designed to aid people with hearing loss. The company offers hearing devices and implants, diagnostic instruments and personal communication devices. Its product …
  • Korea Petrochemical Ind. Co Ltd (006650):企業の財務・戦略的SWOT分析
    Summary Korea Petrochemical Ind. Co Ltd (KPICL) is a chemical company that manufactures and markets petrochemical products. The company provides products such as olefins, aromatics, polypropylene, EO and EG, PP and HDPE. It provides olefins products such as ethylene, propylene, butene, butane, isobu …
  • Lab21 Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Lab21 Ltd (Lab21), a subsidiary of Novacyt SA, is a clinical laboratory that offers clinical diagnostic testing services. The company develops molecular diagnostics for oncology and virology. Its oncology includes KRAS, EGFR, BRAF, ALK, RAS-RAF, BRCA, prostate cancer, among others. Lab21’s v …
  • Bourbon SA (GBB)-石油・ガス分野:企業M&A・提携分析
    Summary Bourbon SA (Bourbon) is a provider of marine and subsea services to the oil and gas industry. The company’s services consist of transport and supply of offshore material, floating production, storage and offloading (FPSO) support, anchor handling, towage and offshore positioning, assistance, …
  • Martin Midstream Partners LP (MMLP):企業の財務・戦略的SWOT分析
    Martin Midstream Partners LP (MMLP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • RainDance Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary RainDance Technologies Inc (RDT) is a developer of genomic tools for non-invasive liquid biopsy applications. The company’s products include RainDrop Plus, a digital PCR system that provides picoliter droplets for multiplex detection of HIV and DNA. It also offers RainDrop Plus digital PCR s …
  • Willis Lease Finance Corp (WLFC):企業の財務・戦略的SWOT分析
    Willis Lease Finance Corp (WLFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Cost Plus Inc:企業の戦略的SWOT分析
    Cost Plus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • British Columbia Investment Management Corp:企業の戦略的SWOT分析
    British Columbia Investment Management Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Centre de Regulacio Genomica-製薬・医療分野:企業M&A・提携分析
    Summary Centre de Regulacio Genomica (CRG) is a biomedical institute that provides research services. The institute provides research programs such as bioinformatics and genomics, cell and developmental biology, gene regulation, stem cells and cancer and systems biology, among others. It offers faci …
  • Alafair Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Alafair Biosciences Inc (Alafair Biosciences) is a medical device company that develops and commercialize surgical products for soft tissue repair and protection applications. The company develops products based on a non-cell adhesive hydrogel technology to protect and manage advanced wound …
  • Ophthotech Corp (OPHT):製薬・医療:M&Aディール及び事業提携情報
    Summary Ophthotech Corp (Ophthotech) is a biopharmaceutical company that offers novel therapeutics to treat diseases of the back of the eye for age-related macular degeneration. The company’s products include Zimura, an anti-complemente is a central component of the complement cascade that is suppos …
  • Calumet Specialty Products Partners LP (CLMT):企業の財務・戦略的SWOT分析
    Calumet Specialty Products Partners LP (CLMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Mondelez International Inc (MDLZ):企業の財務・戦略的SWOT分析
    Mondelez International Inc (MDLZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Bank of Ireland:戦略・SWOT・企業財務分析
    Bank of Ireland - Strategy, SWOT and Corporate Finance Report Summary Bank of Ireland - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Getinge AB (GETI B):企業の財務・戦略的SWOT分析
    Getinge AB (GETI B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Dauntless Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Dauntless Pharmaceuticals Inc (Dauntless Pharma) is a drug development company that develops therapeutic agents. The company’s pipeline products include DP1038 and DP2018. Its DP1038 is an intranasal octreotide formulation used as a therapeutic agent for the treatment of acromegaly and neuro …
  • Permian Basin Royalty Trust (PBT):企業の財務・戦略的SWOT分析
    Summary Permian Basin Royalty Trust (Permian Basin Royalty) is an oil and gas company that owns overriding royalty rights in mineral properties in the US. The company provides oil and gas products. It has assets comprises of 75 percent net overriding royalty interest in the Waddell Ranch Properties …
  • Bio-Rad Laboratories, Inc.:戦略・SWOT・企業財務分析
    Bio-Rad Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bio-Rad Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Cargolux Airlines International S.A.:企業の戦略・SWOT・財務分析
    Cargolux Airlines International S.A. - Strategy, SWOT and Corporate Finance Report Summary Cargolux Airlines International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆